In this Issue:
Post-ASCT survival with thalidomide consolidation in MM
Leucodepletion reduces morbidity, not mortality
In vivo kinase inhibition with nilotinib
‘Fast track’ warfarin reversal
Management of primary CNS lymphoma
Spinal MRI in newly diagnosed myeloma
Update on DLI use
Genome sequencing methodologies
Using JAK inhibitors for myelofibrosis
Fibrinogen concentrates/transfusions in major bleeding
New oral anticoagulants
Preparedness for customised CML therapy
Blinatumomab for B-precursor ALL
Inducible caspase 9 for adoptive T-cell therapy
Please login below to download this issue (PDF)